Journal
CELL
Volume 181, Issue 7, Pages 1458-1463Publisher
CELL PRESS
DOI: 10.1016/j.cell.2020.05.041
Keywords
-
Categories
Funding
- NIH [AI142596, AI145687, AI150415, AI058607]
- Department of Defense [HR0011-17-2-0069]
- Translating Duke Health Initiative
Ask authors/readers for more resources
The SARS-CoV-2 pandemic that causes COVID-19 respiratory syndrome has caused global public health and economic crises, necessitating rapid development of vaccines and therapeutic countermeasures. The world-wide response to the COVID-19 pandemic has been unprecedented with government, academic, and private partnerships working together to rapidly develop vaccine and antibody countermeasures. Many of the technologies being used are derived from prior government-academic partnerships for response to other emerging infections.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
